Cardiovascular System Drugs (Ex2) Flashcards
What are 4 cardiac stimulants?
Beta 1 agonists
Phosphodiesterase inhibitors
Glucagon
Calcium salts
What kind of drugs are Digitalis Glycosides?
Name 3 of them
- positive inotropic drugs
- Digitoxin
- Digoxin
- Ouabain
Digoxin
classification, MOA
- digitalis glycoside (pos inotropic)
- inhibits Na-K ATPase in myocardial cell membrane, increasing Na available for exchange with Ca
- results in increase in intracellular Ca leading to positive inotropic effect
Digoxin
cardiovascular effects
- positive inotropic effect
- reduction in sinus rate and slowing AV conduction
- prolonged PR intervals in ECG
- increased mechanical efficiency of failing heart
- normalization of blood pressure and peripheral resistance
Digoxin
effects on kidney and GI tract
Kidney
- diuretic effect secondary to increased cardiac output
GI
- irritation, vomiting, anorexia
Digoxin Pharmacokinetics
- administered orally, can be given slow IV in emergencies
- oral bioavailability better as elixir than tablet
- small amount metabolized in liver
- undergoes hepatic recycling
- excretion renal in dogs and horses, renal and hepatic in cats
Digoxin therapeutic uses and adverse affects
- congestive heart failure
- atrial arrhythmias in dogs
Adverse: narrow safety margin - cats more sensitive than dogs
- tachy and bradyarrhythmias
Predisposing factors for tachyarrhythmias cause by Digoxin
- hypokalemia, hypomagnesemia
- hypercalcemia, hypernatremia
- hypo/hyperthyroidism
- hypoxemia
Treatment of tachyarrhythmia and bradyarrhythmia caused by Digoxin
T: drug withdrawal - potassium IV - antiarrhythmic drugs - cholestyramine - digoxin immune Fab (antibody) B: drug withdrawal - Atropine
What type of drugs are Beta 1 Agonists?
When are they used?
Name 2 drugs
- positive inotropic drugs
- less likely to cause tachyarrhythmias
- only used in emergencies (one dose/shot)
- Dopamine and Dobutamine
Pimobendan
classification, uses
- inodilator (pos inotrope and vasodilator)
- treat CHF in dogs
- as adjunctive therapy in improving quality of life in dogs with heart failure due to dilated cardiomyopathy and degenerative vascular disease
- can be used with furosemide, spironolactone, or ACE in heart failure patients
Pimobendan MOA
- sensitization of the cardiac contractile apparatus to Ca by enhancing interaction between Ca and troponin C complex
- has the potential to increase intracellular Ca and increase myocardial oxygen consumption, bc inhibits PDE III and V, causing vasodilation of arteries and veins, resulting in reduced pre- and afterload
Pimobendan
side effects and contraindications
- may cause diarrhea, vomiting, inappetence, seizures, and PU-PD
- less arrhythmogenic than digitalis
- should not be used in hypertrophic cardiomyopathy or in clinical conditions where increase of cardiac output is not possible
Pimobendan pharmacokinetics
- absorbed rapidly on oral ingestion
- bioavailabilty of 60%
- metabolically activated in liver
- metabolites excreted in feces
- bound to plasma proteins
What are 4 vasodilator drugs?
- ACE Inhibitors (block angiotensin II formation)
- Hydralazine
- Nitrates
- Prazosin
Carvedilol
classification, MOA, uses
- nonselective beta blocker and alpha 1 blocker
- antioxidant
- inhibits endothelin release
- used in early trtmt of CHF due to dilated cardiomyopathy to blunt the harmful effects of sympathetic NS on the heart
What are the 3 mechanisms of arrhythmias?
- abnormal automaticity
- abnormal conductance
- disturbances in both automaticity and impulse conduction
What are the causes of arrhythmias?
- imbalance of sympathetic and parasympathetic
- changes in serum K, Ca, or Mg
- hypoxemia
- acidosis
- mechanical trauma
- myocardial disease
- cardiac ischemia
- myocardial infarction
- drugs